Merck
CN
  • Uterine fibroid embolisation: initial experience in our local population.

Uterine fibroid embolisation: initial experience in our local population.

JPMA. The Journal of the Pakistan Medical Association (2014-01-09)
Rehmani Aniqah Jawad, Imaad-ur-Rehman, Atif Iqbal Rana, Nabia Tariq
摘要

To evaluate the results of uterine fibroid embolisation as a treatment option for symptomatic uterine fibroids in the local population. The retrospective study was done at the Department of Diagnostic and Interventional Radiology, Shifa International Hospital, Islamabad, and comprised records of 12 patients with symptomatic uterine fibroids who had undergone uterine fibroid embolisation with the use of polyvinyl alcohol between May 2008 and July 2012. All of these patients had been assessed by a gynaecologist. Pre-embolisation workup was done by pelvic Magnetic Resonance Imaging. A detailed questionnaire was prepared to assess clinical improvement and interval change in fibroid size on follow-up imaging. A technically successful embolisation was done in all patients. All patients experienced immediate postprocedure pain, but responded to conservative treatment. Clinical follow-up showed a significant reduction in symptoms within six months of the procedure, with 88% improvement in menorrhagia and 100% improvement in pain. Follow-up imaging showed reduction in fibroid sizes ranging from 17-63%. Two patients developed infection, which is a known complication of this procedure. Uterine fibroid embolisation is a well-recognised treatment option for symptomatic uterine fibroids. Ascertaining its long-term results in our local population will, however, require additional studies with larger patient populations.

材料
货号
品牌
产品描述

Sigma-Aldrich
聚乙烯醇, Mw 89,000-98,000, 99+% hydrolyzed
Sigma-Aldrich
聚乙烯醇, 87-90% hydrolyzed, average mol wt 30,000-70,000
Sigma-Aldrich
聚乙烯醇, Mw 9,000-10,000, 80% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Mw 13,000-23,000, 87-89% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Mw 146,000-186,000, 99+% hydrolyzed
Sigma-Aldrich
® 4-88, Mw ~31,000
Sigma-Aldrich
聚乙烯醇, Mw 31,000-50,000, 98-99% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Mw 85,000-124,000, 99+% hydrolyzed
Sigma-Aldrich
聚乙烯醇, Fully hydrolyzed
Sigma-Aldrich
聚乙烯醇, average Mw 85,000-124,000, 87-89% hydrolyzed
Sigma-Aldrich
聚乙烯醇, average Mw 13,000-23,000, 98% hydrolyzed
Sigma-Aldrich
Mowiol® 18-88 聚(乙烯醇), Mw ~130,000
Sigma-Aldrich
聚乙烯醇, average Mw 31,000-50,000, 87-89% hydrolyzed
Sigma-Aldrich
聚乙烯醇, average Mw 146,000-186,000, 87-89% hydrolyzed
Sigma-Aldrich
Mowiol® 8-88, Mw ~67,000
Sigma-Aldrich
聚乙烯醇, average Mw 130,000, 99+% hydrolyzed
Sigma-Aldrich
Mowiol ® 10-98, Mw ~61,000
Sigma-Aldrich
Mowiol ® 40-88, average Mw ~205,000 g/mol
Sigma-Aldrich
Mowiol® 4-98, Mw ~27,000
Sigma-Aldrich
Mowiol® 20-98, Mw ~125,000
Sigma-Aldrich
Mowiol® 28-99聚乙烯醇, Mw ~145,000
Sigma-Aldrich
Mowiol® 56-98, Mw ~195,000
Sigma-Aldrich
Mowiol® 6-98, Mw ~47,000